Results 21 to 30 of about 4,977,677 (230)

Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer

Journal of Cancer Research and Clinical Oncology, 2023
More than 99% of cervical cancers and up to 40% of vulvar cancers are human papillomavirus (HPV) related. HPV 16 and 18 are the most relevant subtypes. Novel technologies allow the detection of minimal amounts of circulating cell-free HPV DNA (ccfHPV-DNA)
F. Thangarajah, J. Busshoff, Janina Salamon, M. Pruss, Caroline Lenz, B. Morgenstern, M. Hellmich, H. A. Schlößer, M. Lenz, C. Domröse, M. Mallmann, P. Mallmann, J. Weiss, Fabian Franzen, S. Merkelbach-Bruse, E. Binot, Marie‐Lisa Eich, R. Büttner, A. Schultheis, C. Alidousty   +19 more
semanticscholar   +1 more source

Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999–2019: Korea Central Cancer Registry

Obstetrics & Gynecology Science, 2023
Objective To investigate the incidence, trends, and survival rates of all gynecologic cancers using the Korea Central Cancer Registry (KCCR) database from 1999–2019.
B. Yun, E. Park, J. Ha, Jung-Yun Lee, K. Lee, Taek Sang Lee, K. Lee, Y. J. Kim, Kyu-Won Jung, J. Roh   +9 more
semanticscholar   +1 more source

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

Journal of Clinical Oncology, 2021
PURPOSE The Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V)-II investigated whether inguinofemoral radiotherapy is a safe alternative to inguinofemoral lymphadenectomy (IFL) in vulvar cancer patients with a metastatic ...
Maaike H. M. Oonk, B. Slomovitz, P. Baldwin, H. V. van Doorn, J. van der Velden, J. D. De hullu, K. Gaarenstroom, B. Slangen, I. Vergote, M. Brännström, E. V. van Dorst, W. V. van Driel, R. Hermans, D. Nunns, M. Widschwendter, D. Nugent, C. Holland, Aarti Sharma, P. DiSilvestro, R. Mannel, D. Boll, D. Cibula, A. Covens, D. Provencher, I. Runnebaum, D. Luesley, P. Ellis, T. Duncan, M. Tjiong, D. Cruickshank, P. Kjølhede, C. Levenback, J. Bouda, K. Kieser, C. Palle, N. Spirtos, D. O’Malley, M. Leitao, M. Geller, K. Dhar, V. Asher, K. Tamussino, D. Tobias, C. Borgfeldt, J. Lea, J. Bailey, M. Lood, B. Eyjólfsdóttir, S. Attard-Montalto, K. Tewari, R. Manchanda, P. T. Jensen, P. Persson, L. Van Le, H. Putter, G. D. de Bock, B. Monk, C. Creutzberg, A. van der Zee   +58 more
semanticscholar   +1 more source

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines

Gynecologic Oncology Reports, 2022
There are limited treatment options for patients with advanced vulvar cancer. However, several immune checkpoint inhibitors (ICIs) are FDA-approved or NCCN-Compendia–listed for qualified patients with advanced disease.
Aaron Praiss, Anastasia Navitski, Seth Cohen, Basile Tessier-Cloutier, Vance Broach, Roisin E. O'Cearbhaill   +5 more
doaj   +1 more source

New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors

Cancers, 2022
Simple Summary Vulvar cancer incidence data were sought from official sources (WHO Cancer Incidence in Five Continents) and studies reporting comparable data.
L. Bucchi, M. Pizzato, S. Rosso, S. Ferretti   +3 more
semanticscholar   +1 more source

Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer [PDF]

Obstetrics & Gynecology Science, 2022
Objective To demonstrate near-infrared fluorescence image-guided inguinal sentinel lymph node (SLN) biopsy in patients with vulvar cancer. Methods A 40-year-old woman with a 3-cm-sized palpable left vulvar mass was diagnosed with vulvar cancer on biopsy ...
Young Hwa Kwak, Yong Jae Lee, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Young Tae Kim, Sang Wun Kim   +6 more
doaj   +1 more source

Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging

Cancers, 2022
Simple Summary Primary vulvar malignancy is a rare gynecological neoplasm constituting 5–8% of cases. Considering the prognostic capability of staging, FIGO has introduced the revised 2021 staging for vulvar cancer. We review the etiopathogenesis revised
Mayur K. Virarkar, S. S. Vulasala, Taher Daoud, S. Javadi, C. Lall, P. Bhosale   +5 more
semanticscholar   +1 more source

Management of Early-Stage Vulvar Cancer

Cancers, 2022
Simple Summary Vulvar cancer is a rare gynecological malignancy that affects mainly postmenopausal women. Recently, however, an alarming increase in the rates among young women has been observed due to human papillomavirus infection.
P. G. Pedrão, Yasmin Medeiros Guimarães, L. R. Godoy, J. C. Possati-Resende, A. Bovo, C. Andrade, A. Longatto-Filho, R. Dos Reis   +7 more
semanticscholar   +1 more source

Complications and risk factors in vulvar cancer surgery - A population-based study.

European Journal of Surgical Oncology, 2022
INTRODUCTION Primary surgery for vulvar cancer has become less radical in past decades. This study investigates risk factors and prevalence of short-and long-term complications after up-to-date vulvar cancer surgery.
Camilla Rahm, C. Adok, P. Dahm-Kähler, K. Bohlin   +3 more
semanticscholar   +1 more source

The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer

The journal of obstetrics and gynaecology research, 2021
The present article aims to highlight the importance of changes of personalized surgical treatment for vulvar cancer. Current international literature regarding surgical treatment of vulvar cancer was evaluated.
A. Giannini, O. D’Oria, B. Chiofalo, V. Bruno, E. Baiocco, E. Mancini, R. Mancari, C. Vincenzoni, G. Cutillo, E. Vizza   +9 more
semanticscholar   +1 more source